Brown-Elliott, Barbara A., MS,MT(ASCP)SM

← BACK  

Brown-Elliott, Barbara A., MS,MT(ASCP)SM
Research Assistant Professor, Microbiology
Supervisor, Mycobacteria/Nocardia Laboratory

Contact: Barbara.Elliott@uthct.edu

Research Interests:

Mycobacteria, Nocardia, other aerobic actinomycetes

Research Overview:

• Antimicrobial susceptibility testing and the study of antibiotics in the treatment of infections caused by nontuberculous mycobacteria( NTM), Nocardia and other aerobic actinomycetes.
• Testing of new antibiotics and development of better standardization of antimicrobial susceptibility test methods for the NTM, Nocardia and other aerobic actinomycetes. Defining mechanisms and genetics of drug resistance in the NTM.
• Characterization and taxonomy of new pathogenic ( disease producing) species of NTM and Nocardia. Previous studies have resulted in naming of several new species, including Mycobacterium mucogenicum, Mycobacterium goodii, Mycobacterium wolinskyi, Mycobacterium bacteremicum, Mycobacterium franklinii, Nocardia pseudobrasiliensis, and Nocardia wallacei.

Selected publications:

• Brown-Elliott BA, Wallace RJ Jr: Rapidly growing mycobacteria. In: Tuberculosis & Nontuberculous Mycobacterial Infections, 6th edition, D Schlossberg, ed. McGraw-Hill Companies, Inc., pp. 565-577, 2011.
• Brown-Elliott BA, Wallace RJ Jr.: Mycobacterium: Clinical and Laboratory Characteristics of rapidly growing mycobacteria. In: Manual of Clinical Microbiology, 10th Edition, J. Versalovic, ed. ASM Press, Washington, D.C. , Vol. 1, pp. 525-538, 2011.
• Richter E, Brown-Elliott BA, Wallace RJ Jr.: Mycobacterium: Laboratory characteristics of slowly growing mycobacteria. In: Manual of Clinical Microbiology, 10th Edition, J. Versalovic, ed. ASM Press, Washington, D.C., Vol. 1, pp. 503-524, 2011.
• Woods GL, Brown-Elliott BA, Conville PS, et al.: Susceptibility testing of mycobacteria, nocardia, and other aerobic actinomycetes; Approved Standard - Second edition. CLSI, M24-A2, 2011.
• Brown-Elliott BA, Wallace RJ Jr.: Mycobacterium: Clinical and laboratory characteristics of rapidly growing mycobacteria. In: Manual of Clinical Microbiology, 10th Edition, J. Versalovic, ed. ASM Press, Washington, D.C. Volume 1, pp. 525-538, 2011.B
• Brown-Elliott BA, Wallace RJ Jr., Petti CA, et al.: Mycobacterium neoaurum and Mycobacterium bacteremicum sp. nov. as causes of mycobacteremia. J. Clin. Microbiol. 48:4377-4385, 2010.
• Brown-Elliott BA, Wallace RJ Jr: Infections due to nontuberculous mycobacteria other than Mycobacterium avium-intracellulare. In: Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases, Seventh Edition, Mandell, Bennett, Dolin, eds, Elsevier Churchill Livingstone Inc., Vol. 2, 253: 3191-3198, 2010.
• Nash KA, Brown-Elliott BA, Wallace RJ Jr: A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae. Antimicrob. Agents Chemother. 53:1367-1376, 2009.
• Forbes, BA, Banaiee N, Beavis KG, Brown-Elliott BA, et al.: Laboratory detection and identification of mycobacteria; Approved Guideline. Clinical and Laboratory Institute (CLSI) Document M48-A, 2008.
• Brown-Elliott, BA, Cohen, S, Wallace RJ Jr.: Susceptibility testing of mycobacteria. In: Antimicrobial Susceptibility Testing Protocols, R Schwalbe, L Steele-Moore, AC Goodwin, eds. CRC Press, Boca Raton, FL. 11:243-274, 2007.
• Griffith DE, Aksamit T, Brown-Elliott BA, et al.: An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am. J. Respir. Crit. Care Med. 175:367-416, 2007.
• Griffith DE, Brown-Elliott BA, Langsjoen B, et al.: Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am. J. Respir. Crit. Care Med. 174:928-934, 2006.
• Brown-Elliott BA, Brown JM, Conville PS, Wallace RJ Jr: Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin. Microbiol. Rev. 19:259-282, 2006.
• Brown-Elliott BA, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr: In vitro activity of linezolid against slowly growing nontuberculous mycobacteria. Antimicrob. Agents Chemother. 47:1736-1738, 2003.